NIH-funded research NIH-funded research

Noninvasive brain stimulation to reduce hyperexcitability in a Fragile X rat model

Official title: Repetitive transcranial magnetic stimulation to reduce hyperexcitability in Fmr1 knockout rats

Funded at Kansas State University · NIH-11594745 · Data updated 2026-11-12

A small animal study tests whether low-frequency rTMS can calm overactive brain activity and improve thinking-style tasks in a rat model of Fragile X and autism.

More Transcranial Magnetic Stimulation research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionKansas State University
NIH-funded
Lab location1 site (Manhattan, United States)
Project startJune 1, 2026
Project endMay 31, 2027
Funding year2026
Award (this year)$193,041
NIH project number5P20GM113109-10
Project IDNIH-11594745 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with Fragile X syndrome or autism with similar cognitive and behavioral profiles, should human trials prove feasible.

Less likely to help

This study uses animals, so direct patient benefit is not anticipated from this specific work.

What this research studies

This project uses a rat model of Fragile X syndrome to test whether applying low-frequency repetitive transcranial magnetic stimulation to the prefrontal cortex can reduce brain hyperexcitability and alter gamma activity. The researchers will assess changes in anxiety, memory, and cognitive flexibility through three behavioral tasks, followed by brain recordings to measure multi-unit activity and local field potentials. After stimulation, the same tests will be repeated to see how results track with neural changes. The goal is to identify potential translational biomarkers that could guide future human studies and help people with Fragile X/ASD.

Why it matters

Potential benefit: If successful, this approach could inform new noninvasive treatments to improve cognitive processing and reduce anxiety in Fragile X and autism.

How similar studies have gone: Previous work in animal models suggests rTMS can modulate brain activity, but translational success to humans remains to be demonstrated.

Where this research is happening

  • Kansas State University
    Manhattan, United States
    Active

Researchers

  • Principal investigator: Plakke Anderson, Bethany — Kansas State University
  • Study coordinator: Plakke Anderson, Bethany

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.